Regal Assets Analytics

Call Us: (800) 891-1526

M - F 8AM to 4PM ET

Pharmaceutical & Biotechnology

Gritstone, BioXcel Expect to Report Catalysts in July 2020; 2Q SanaCurrents Update

By |2020-07-06T12:50:14-04:00July 6th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|

Gritstone Oncology (NASDAQ:GRTS) plans to hold a conference call and [...]

Molecular Templates (MTEM) Probability Sentiment

By |2020-07-06T10:24:03-04:00June 13th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|

Molecular Templates, Inc. (NASDAQ:MTEM) Probability Sentiment [...]

Selecta Licenses Away Promising Gout Drug; SanaCurrents Suspending Coverage

By |2020-07-06T10:24:12-04:00June 12th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents Updates|Tags: , , |

After the market closed on June 11, Selecta Biosciences, Inc. [...]

Intra-Cellular Therapies, Inc. (ITCI) Probability Sentiment

By |2020-06-01T12:38:58-04:00May 23rd, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|Tags: |

ITCI Probability Sentiment CATALYST SUMMARY [...]

SanaCurrents Following Stock Highs After Coronavirus Developments

By |2020-05-05T08:58:49-04:00May 4th, 2020|Categories: Bill Langbein, Healthcare, Insights, Pharmaceutical & Biotechnology|Tags: |

Last Friday, the FDA granted emergency use authorization (EUA) to [...]

Summit Therapeutics (SMMT) Probability Sentiment

By |2020-05-21T14:34:28-04:00April 19th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|Tags: , |

Summit Therapeutics plc (NASDAQ:SMMT) Probability Sentiment [...]

Acceleron Hits Second Catalyst; Eight More SanaCurrents Catalysts Expected For 2Q 2020

By |2020-04-15T11:07:58-04:00April 15th, 2020|Categories: Bill Langbein, Health Care Equipment & Services, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: , , , , , , , , , |

Onconova Coverage suspended, Oragenics falls short in Phase II trial.   [...]